The Clinical Core serves as an interface between basic science, clinical, behavioral, and epidemiological investigators and patients with HIV disease. Through the establishment of multiple clinics, a Comprehensive Clinical Database, and a Tissue Specimen Repository, the Clinical Core serves as a hub"""""""" for all patient-related activities, ranging from the conduct of clinical trials to provisions of clinical specimens and clinical outcome information to the 100+ UAB CFAR investigators and investigators around the world. The specific objectives of the Clinical Core are to: 1) Provide an infrastructure for the conduct of clinical studies on HIV- infected children and adults as well as non-HIV-infect participants in HIV-related vaccine studies. 2) Maintain and provide continuous (real time) update of the 1917 Clinic Database, which is used to perform clinical, pharmaco-economic, and psycho-social outcome studies and to identify patients for participation in clinical and basic science research projects. 3) Collect, process, store, and distribute clinical specimens from well- characterized patients to basic science and clinical investigators through a Comprehensive Clinical Specimen Repository. 4) Provide pharmacological analyses in conjunction with clinical and basic science studies utilizing innovative, state-of-the-art methodologies to evaluate pharmacodynamic effects of new drugs on the biology of HIV in vivo and on clinical outcome. 5) Provide clinical trials and data management staff to conduct state-of- the-art investigations of treatment of AIDS-related malignancies in oncologic processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027767-15
Application #
6584123
Study Section
Project Start
2002-03-01
Project End
2003-02-28
Budget Start
Budget End
Support Year
15
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Smith, Samuel R; Schaaf, Kaitlyn; Rajabalee, Nusrah et al. (2018) The phosphatase PPM1A controls monocyte-to-macrophage differentiation. Sci Rep 8:902
Wang, Yong; Schafer, Cara C; Hough, Kenneth P et al. (2018) Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol 201:278-295
Jones, Robert B; Dorsett, Kaitlyn A; Hjelmeland, Anita B et al. (2018) The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1? signaling. J Biol Chem 293:5659-5667
Frugé, Andrew D; Van der Pol, William; Rogers, Laura Q et al. (2018) Fecal Akkermansia muciniphila Is Associated with Body Composition and Microbiota Diversity in Overweight and Obese Women with Breast Cancer Participating in a Presurgical Weight Loss Trial. J Acad Nutr Diet :
Dionne-Odom, Jodie; Westfall, Andrew O; Van Der Pol, Barbara et al. (2018) Sexually Transmitted Infection Prevalence in Women With HIV: Is There a Role for Targeted Screening? Sex Transm Dis 45:762-769
Crenshaw, Brennetta J; Gu, Linlin; Sims, Brian et al. (2018) Exosome Biogenesis and Biological Function in Response to Viral Infections. Open Virol J 12:134-148
Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325
Sahay, Bikash; Bashant, Kathleen; Nelson, Nicole L J et al. (2018) Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling. Infect Immun 86:
Trapecar, Martin; Khan, Shahzada; Cohn, Benjamin L et al. (2018) B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection. Mucosal Immunol 11:1158-1167
Verma, Richa; Sahu, Rajnish; Dixit, Saurabh et al. (2018) The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic Front Immunol 9:2369

Showing the most recent 10 out of 955 publications